130 organizations and cancer centers underscore the importance of prioritizing patients with active cancer and survivors of cancer for lifesaving COVID-19 vaccines.
|
The 2025 American Society of Clinical Oncology Annual (ASCO) Meeting was held in Chicago, Illinois, May 30-June 3. Many Rogel researchers participated in presentations, poster sessions and panel discussions before an audience of cancer researchers from around the globe. Read on for the highlights.
|
Researchers from the University of Michigan received a $6 million center grant from the National Institutes of Health to establish the new National Center for Biomedical Imaging and Bioengineering. The center will be dedicated to microsystems-based imaging systems.
|
Rogel Cancer Center receives $50M gift from Richard and Susan Rogel to aim to revolutionize how the world detects, treats, and ultimately cures pancreatic cancer.
|
Patients with cancer-linked variants in ATM, CHEK2 or PALB2 genes do not have a greater risk of dying from their disease, research finds
|
In combination with radiation therapy, treatment vastly improved mouse survival
|
Simultaneous targeting of PIKfyve and KRAS-MAPK eliminates tumors in preclinical human and mouse models
|
Bazedoxifene and conjugated estrogens reversed obesity-associated changes, supporting their use in patients
|
Between 2010 and 2024, the number of men undergoing surgery for low risk prostate cancer dropped more than fivefold
|
The American Society of Clinical Oncology’s annual meeting will be May 30 to June 3, 2025, at McCormick Place Convention Center in Chicago.
Rogel Cancer Center and University of Michigan researchers will be represented in presentations and poster sessions.
|
|
|
MENU